Skip to main content
Top
Published in: Journal of Neural Transmission 1/2017

Open Access 01-02-2017 | Psychiatry and Preclinical Psychiatric Studies − Review Article

Sleep and inflammatory markers in different psychiatric disorders

Authors: Krzysztof Krysta, Marek Krzystanek, Agnieszka Bratek, Irena Krupka-Matuszczyk

Published in: Journal of Neural Transmission | Special Issue 1/2017

Login to get access

Abstract

Many psychiatric disorders, like schizophrenia, affective disorders, addictions and different forms of dementia are associated with sleep disturbances. In the etiology and course of those diseases inflammatory processes are regarded to be an increasingly important factor. They are also a frequently discussed element of the pathology of sleep. In this literature review reports on correlations between poor sleep and inflammatory responses in various psychiatric conditions are discussed. The link between schizophrenia, affective disorders and inflammatory cytokines is a complex phenomenon, which has been already confirmed in a number of studies. However, the presence of sleep deficits in those conditions, being a common symptom of depression and psychoses, can be an additional factor having a considerable impact on the immunological processes in mental illnesses. In the analyzed data, a number of studies are presented describing the role of inflammatory markers in sleep disturbances and psychopathological symptoms of affective, psychotic, neurogenerative and other disorders. Also attention is drawn to possible implications for their treatment. Efforts to use, e.g., anti-inflammatory agents in psychiatry in the context of their impact on sleep are reported. The aspect of inflammatory markers in the role of sleep deprivation as the treatment method in major depressive disorder is also discussed. A general conclusion is drawn that the improvement of sleep quality plays a crucial role in the care for psychiatric patients.
Literature
go back to reference Afonso P, Brissos S, Figueira ML, Paiva T (2010) Discrepant nocturnal melatonin levels in monozygotic twins discordant for schizophrenia and its impact on sleep. Schizophr Res 120:227–228CrossRefPubMed Afonso P, Brissos S, Figueira ML, Paiva T (2010) Discrepant nocturnal melatonin levels in monozygotic twins discordant for schizophrenia and its impact on sleep. Schizophr Res 120:227–228CrossRefPubMed
go back to reference Ali T, Orr WC (2014) Sleep disturbances and inflammatory bowel disease. Inflamm Bowel Dis 20:1986–1995CrossRefPubMed Ali T, Orr WC (2014) Sleep disturbances and inflammatory bowel disease. Inflamm Bowel Dis 20:1986–1995CrossRefPubMed
go back to reference Anderson G, Maes M (2012) Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects. Metab Brain Dis 27:113–119CrossRefPubMed Anderson G, Maes M (2012) Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects. Metab Brain Dis 27:113–119CrossRefPubMed
go back to reference Appelberg B, Katila H, Rimon R (1997) Plasma interleukin-1 beta and sleep architecture in schizophrenia and other nonaffective psychoses. Psychosom Med 59:529–532CrossRefPubMed Appelberg B, Katila H, Rimon R (1997) Plasma interleukin-1 beta and sleep architecture in schizophrenia and other nonaffective psychoses. Psychosom Med 59:529–532CrossRefPubMed
go back to reference Berk M, Dean O, Drexhage H, McNeil JJ, Moylan S, O’Neil A, Davey CG, Sanna L, Maes M (2013) Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness. BMC Med 11:74CrossRefPubMedPubMedCentral Berk M, Dean O, Drexhage H, McNeil JJ, Moylan S, O’Neil A, Davey CG, Sanna L, Maes M (2013) Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness. BMC Med 11:74CrossRefPubMedPubMedCentral
go back to reference Bersani G, Mameli M, Garavini A, Pancheri P, Nordio M (2003) Reduction of night/day difference in melatonin blood levels as a possible disease-related index in schizophrenia. Neuro Endocrinol Lett 24:181–184PubMed Bersani G, Mameli M, Garavini A, Pancheri P, Nordio M (2003) Reduction of night/day difference in melatonin blood levels as a possible disease-related index in schizophrenia. Neuro Endocrinol Lett 24:181–184PubMed
go back to reference Besedovsky HO, del Rey A, Sorkin E, DaPrada M, Burri R, Honegger C (1983) The immune response evokes changes in brain noradrenergic neurons. Science 221:564–566CrossRefPubMed Besedovsky HO, del Rey A, Sorkin E, DaPrada M, Burri R, Honegger C (1983) The immune response evokes changes in brain noradrenergic neurons. Science 221:564–566CrossRefPubMed
go back to reference Boakye PA, Olechowski C, Rashiq S, Verrier MJ, Kerr B, Witmans M, Baker G, Joyce A, Dick BD (2015) A critical review of neurobiological factors involved in the interactions between chronic pain, depression, and sleep disruption. Clin J Pain. doi:10.1097/ajp.0000000000000260 Boakye PA, Olechowski C, Rashiq S, Verrier MJ, Kerr B, Witmans M, Baker G, Joyce A, Dick BD (2015) A critical review of neurobiological factors involved in the interactions between chronic pain, depression, and sleep disruption. Clin J Pain. doi:10.​1097/​ajp.​0000000000000260​
go back to reference Buysse DJ, Angst J, Gamma A, Ajdacic V, Eich D, Rossler W (2008) Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep 31:473–480PubMedPubMedCentral Buysse DJ, Angst J, Gamma A, Ajdacic V, Eich D, Rossler W (2008) Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep 31:473–480PubMedPubMedCentral
go back to reference Cazzullo CL, Scarone S, Grassi B, Vismara C, Trabattoni D, Clerici M (1998) Cytokines production in chronic schizophrenia patients with or without paranoid behaviour. Prog Neuropsychopharmacol Biol Psychiatry 22:947–957CrossRefPubMed Cazzullo CL, Scarone S, Grassi B, Vismara C, Trabattoni D, Clerici M (1998) Cytokines production in chronic schizophrenia patients with or without paranoid behaviour. Prog Neuropsychopharmacol Biol Psychiatry 22:947–957CrossRefPubMed
go back to reference Chaudhry IB, Hallak J, Husain N, Minhas F, Stirling J, Richardson P, Dursun S, Dunn G, Deakin B (2012) Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment. J Psychopharmacol 26:1185–1193CrossRefPubMed Chaudhry IB, Hallak J, Husain N, Minhas F, Stirling J, Richardson P, Dursun S, Dunn G, Deakin B (2012) Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment. J Psychopharmacol 26:1185–1193CrossRefPubMed
go back to reference Chen R, Yin Y, Zhao Z, Huang L, Huang S, Zhuang J, Wu H, Peng H, Li P (2012) Elevation of serum TNF-alpha levels in mild and moderate Alzheimer patients with daytime sleepiness. J Neuroimmunol 244:97–102CrossRefPubMed Chen R, Yin Y, Zhao Z, Huang L, Huang S, Zhuang J, Wu H, Peng H, Li P (2012) Elevation of serum TNF-alpha levels in mild and moderate Alzheimer patients with daytime sleepiness. J Neuroimmunol 244:97–102CrossRefPubMed
go back to reference Cohrs S (2008) Sleep disturbances in patients with schizophrenia: impact and effect of antipsychotics. CNS Drugs 22:939–962CrossRefPubMed Cohrs S (2008) Sleep disturbances in patients with schizophrenia: impact and effect of antipsychotics. CNS Drugs 22:939–962CrossRefPubMed
go back to reference Dameshek W (1930) White blood cells in dementia praecox and dementia paralytietwa. Arch Neurol Psychiatry 24:855 Dameshek W (1930) White blood cells in dementia praecox and dementia paralytietwa. Arch Neurol Psychiatry 24:855
go back to reference Dean OM, Data-Franco J, Giorlando F, Berk M (2012) Minocycline: therapeutic potential in psychiatry. CNS Drugs 26:391–401CrossRefPubMed Dean OM, Data-Franco J, Giorlando F, Berk M (2012) Minocycline: therapeutic potential in psychiatry. CNS Drugs 26:391–401CrossRefPubMed
go back to reference Drexhage RC, Knijff EM, Padmos RC, Heul-Nieuwenhuijzen L, Beumer W, Versnel MA, Drexhage HA (2010) The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder. Expert Rev Neurother 10:59–76CrossRefPubMed Drexhage RC, Knijff EM, Padmos RC, Heul-Nieuwenhuijzen L, Beumer W, Versnel MA, Drexhage HA (2010) The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder. Expert Rev Neurother 10:59–76CrossRefPubMed
go back to reference Ehlers CL, Reed TK, Henriksen SJ (1986) Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 42:467–474CrossRefPubMed Ehlers CL, Reed TK, Henriksen SJ (1986) Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 42:467–474CrossRefPubMed
go back to reference Fernstrom JD, Faller DV (1978) Neutral amino acids in the brain: changes in response to food ingestion. J Neurochem 30:1531–1538CrossRefPubMed Fernstrom JD, Faller DV (1978) Neutral amino acids in the brain: changes in response to food ingestion. J Neurochem 30:1531–1538CrossRefPubMed
go back to reference Fillman SG, Weickert TW, Lenroot RK, Catts SV, Bruggemann JM, Catts VS, Weickert CS (2015) Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca’s area volume. Mol Psychiatry. doi:10.1038/mp.2015.90 PubMedPubMedCentral Fillman SG, Weickert TW, Lenroot RK, Catts SV, Bruggemann JM, Catts VS, Weickert CS (2015) Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca’s area volume. Mol Psychiatry. doi:10.​1038/​mp.​2015.​90 PubMedPubMedCentral
go back to reference Fond G, Girerd N, Clavel F, Tamouza R, Leboyer M (2014) Recently discovered properties of aspirin may be doubly helpful in bipolar disorders. Med Hypotheses 82:640–641CrossRefPubMed Fond G, Girerd N, Clavel F, Tamouza R, Leboyer M (2014) Recently discovered properties of aspirin may be doubly helpful in bipolar disorders. Med Hypotheses 82:640–641CrossRefPubMed
go back to reference Hayaishi O (1991) Molecular mechanisms of sleep-wake regulation; roles of prostaglandins D2 and E2. FASEB J 5:2575–2581PubMed Hayaishi O (1991) Molecular mechanisms of sleep-wake regulation; roles of prostaglandins D2 and E2. FASEB J 5:2575–2581PubMed
go back to reference Heffner KL, Ng HM, Suhr JA, France CR, Marshall GD, Pigeon WR, Moynihan JA (2012) Sleep disturbance and older adults’ inflammatory responses to acute stress. Am J Geriatr Psychiatry 20:744–752CrossRefPubMedPubMedCentral Heffner KL, Ng HM, Suhr JA, France CR, Marshall GD, Pigeon WR, Moynihan JA (2012) Sleep disturbance and older adults’ inflammatory responses to acute stress. Am J Geriatr Psychiatry 20:744–752CrossRefPubMedPubMedCentral
go back to reference Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71:171–186CrossRefPubMed Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71:171–186CrossRefPubMed
go back to reference Illi J, Miaskowski C, Cooper B, Levine JD, Dunn L, West C, Dodd M, Dhruva A, Paul SM, Baggott C, Cataldo J, Langford D, Schmidt B, Aouizerat BE (2012) Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression. Cytokine 58:437–447CrossRefPubMedPubMedCentral Illi J, Miaskowski C, Cooper B, Levine JD, Dunn L, West C, Dodd M, Dhruva A, Paul SM, Baggott C, Cataldo J, Langford D, Schmidt B, Aouizerat BE (2012) Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression. Cytokine 58:437–447CrossRefPubMedPubMedCentral
go back to reference Irwin M (2002) Effects of sleep and sleep loss on immunity and cytokines. Brain Behav Immun 16:503–512CrossRefPubMed Irwin M (2002) Effects of sleep and sleep loss on immunity and cytokines. Brain Behav Immun 16:503–512CrossRefPubMed
go back to reference Irwin M, Rinetti G, Redwine L, Motivala S, Dang J, Ehlers C (2004) Nocturnal proinflammatory cytokine-associated sleep disturbances in abstinent African American alcoholics. Brain Behav Immun 18:349–360CrossRefPubMed Irwin M, Rinetti G, Redwine L, Motivala S, Dang J, Ehlers C (2004) Nocturnal proinflammatory cytokine-associated sleep disturbances in abstinent African American alcoholics. Brain Behav Immun 18:349–360CrossRefPubMed
go back to reference Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S (2006) Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 166:1756–1762CrossRefPubMed Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S (2006) Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 166:1756–1762CrossRefPubMed
go back to reference Jhamnani K, Shivakumar V, Kalmady S, Rao NP, Venkatasubramanian G (2013) Successful use of add-on minocycline for treatment of persistent negative symptoms in schizophrenia. J Neuropsychiatry Clin Neurosci 25:E06–E07CrossRefPubMed Jhamnani K, Shivakumar V, Kalmady S, Rao NP, Venkatasubramanian G (2013) Successful use of add-on minocycline for treatment of persistent negative symptoms in schizophrenia. J Neuropsychiatry Clin Neurosci 25:E06–E07CrossRefPubMed
go back to reference Kang WS, Park HJ, Chung JH, Kim JW (2013) REM sleep deprivation increases the expression of interleukin genes in mice hypothalamus. Neurosci Lett 556:73–78CrossRefPubMed Kang WS, Park HJ, Chung JH, Kim JW (2013) REM sleep deprivation increases the expression of interleukin genes in mice hypothalamus. Neurosci Lett 556:73–78CrossRefPubMed
go back to reference Kapsimalis F, Richardson G, Opp MR, Kryger M (2005) Cytokines and normal sleep. Curr Opin Pulm Med 11:481–484CrossRefPubMed Kapsimalis F, Richardson G, Opp MR, Kryger M (2005) Cytokines and normal sleep. Curr Opin Pulm Med 11:481–484CrossRefPubMed
go back to reference Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB (2014) Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry 71:1121–1128CrossRefPubMedPubMedCentral Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB (2014) Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry 71:1121–1128CrossRefPubMedPubMedCentral
go back to reference Krueger JM, Clinton JM, Winters BD, Zielinski MR, Taishi P, Jewett KA, Davis CJ (2011) Involvement of cytokines in slow wave sleep. Prog Brain Res 193:39–47CrossRefPubMedPubMedCentral Krueger JM, Clinton JM, Winters BD, Zielinski MR, Taishi P, Jewett KA, Davis CJ (2011) Involvement of cytokines in slow wave sleep. Prog Brain Res 193:39–47CrossRefPubMedPubMedCentral
go back to reference Kunz M, Cereser KM, Goi PD, Fries GR, Teixeira AL, Fernande BS, Belmonte-de-Abreu PS, Kauer-Sant’Anna M, Kapczinski F, Gama CS (2011) Serum levels of IL-6, IL-10 and TNF-alpha in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Rev Bras Psiquiatr 33:268–274CrossRefPubMed Kunz M, Cereser KM, Goi PD, Fries GR, Teixeira AL, Fernande BS, Belmonte-de-Abreu PS, Kauer-Sant’Anna M, Kapczinski F, Gama CS (2011) Serum levels of IL-6, IL-10 and TNF-alpha in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Rev Bras Psiquiatr 33:268–274CrossRefPubMed
go back to reference Maes M, Bosmans E, Meltzer HY (1995) Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol. Eur Arch Psychiatry Clin Neurosci 245:172–178CrossRefPubMed Maes M, Bosmans E, Meltzer HY (1995) Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol. Eur Arch Psychiatry Clin Neurosci 245:172–178CrossRefPubMed
go back to reference Maldonado MD, Pérez-San-Gregorio MA, Reiter RJ (2009) The role of melatonin in the immuno-neuro-psychology of mental disorders. Recent Pat CNS Drug Discov 4:61–69CrossRefPubMed Maldonado MD, Pérez-San-Gregorio MA, Reiter RJ (2009) The role of melatonin in the immuno-neuro-psychology of mental disorders. Recent Pat CNS Drug Discov 4:61–69CrossRefPubMed
go back to reference Matsumura H, Nakajiima T, Osaka T, Satoh S, Kawase K, Kubo E, Kantha SS, Kasahara K, Hayaishi O (1994) Prostaglandin D2-sensitive, sleep-promoting zone defined in the ventral surface of the rostral basal forebrain. Proc Natl Acad Sci USA 91:11998–20002CrossRefPubMedPubMedCentral Matsumura H, Nakajiima T, Osaka T, Satoh S, Kawase K, Kubo E, Kantha SS, Kasahara K, Hayaishi O (1994) Prostaglandin D2-sensitive, sleep-promoting zone defined in the ventral surface of the rostral basal forebrain. Proc Natl Acad Sci USA 91:11998–20002CrossRefPubMedPubMedCentral
go back to reference Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, Mullington JM (2004) Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43:678–683CrossRefPubMed Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, Mullington JM (2004) Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43:678–683CrossRefPubMed
go back to reference Merill JE (1992) Tumor necrosis factor alpha, Interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 14:l–10 Merill JE (1992) Tumor necrosis factor alpha, Interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 14:l–10
go back to reference Meyer U, Feldon J, Dammann O (2011) Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res 69:26–33CrossRef Meyer U, Feldon J, Dammann O (2011) Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res 69:26–33CrossRef
go back to reference Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70:663–671CrossRefPubMedPubMedCentral Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70:663–671CrossRefPubMedPubMedCentral
go back to reference Mills PJ, Ancoli-Israel S, von Kanel R, Mausbach BT, Aschbacher K, Patterson TL, Ziegler MG, Dimsdale JE, Grant I (2009) Effects of gender and dementia severity on Alzheimer’s disease caregivers’ sleep and biomarkers of coagulation and inflammation. Brain Behav Immun 23:605–610CrossRefPubMed Mills PJ, Ancoli-Israel S, von Kanel R, Mausbach BT, Aschbacher K, Patterson TL, Ziegler MG, Dimsdale JE, Grant I (2009) Effects of gender and dementia severity on Alzheimer’s disease caregivers’ sleep and biomarkers of coagulation and inflammation. Brain Behav Immun 23:605–610CrossRefPubMed
go back to reference Miyaoka T, Wake R, Furuya M, Liaury K, Ieda M, Kawakami K, Tsuchie K, Taki M, Ishihara K, Araki T, Horiguchi J (2012) Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry 37:222–226CrossRefPubMed Miyaoka T, Wake R, Furuya M, Liaury K, Ieda M, Kawakami K, Tsuchie K, Taki M, Ishihara K, Araki T, Horiguchi J (2012) Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry 37:222–226CrossRefPubMed
go back to reference Moller-Levet CS, Archer SN, Bucca G, Laing EE, Slak A, Kabiljo R, Lo JC, Santhi N, von Schantz M, Smith CP, Dijk DJ (2013) Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc Natl Acad Sci USA 110:E1132–E1141CrossRefPubMedPubMedCentral Moller-Levet CS, Archer SN, Bucca G, Laing EE, Slak A, Kabiljo R, Lo JC, Santhi N, von Schantz M, Smith CP, Dijk DJ (2013) Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc Natl Acad Sci USA 110:E1132–E1141CrossRefPubMedPubMedCentral
go back to reference Monteleone P, Maj M, Fusco M, Kemali D, Reiter RJ (1992) Depressed nocturnal plasma melatonin levels in drug-free paranoid schizophrenics. Schizophr Res 7:77–84CrossRefPubMed Monteleone P, Maj M, Fusco M, Kemali D, Reiter RJ (1992) Depressed nocturnal plasma melatonin levels in drug-free paranoid schizophrenics. Schizophr Res 7:77–84CrossRefPubMed
go back to reference Monteleone P, Natale M, La Rocca A, Maj M (1997) Decreased nocturnal secretion of melatonin in drug-free schizophrenics: no change after subchronic treatment with antipsychotics. Neuropsychobiology 36:159–163CrossRefPubMed Monteleone P, Natale M, La Rocca A, Maj M (1997) Decreased nocturnal secretion of melatonin in drug-free schizophrenics: no change after subchronic treatment with antipsychotics. Neuropsychobiology 36:159–163CrossRefPubMed
go back to reference Monti JM, BaHammam AS, Pandi-Perumal SR, Bromundt V, Spence DW, Cardinali DP, Brown GM (2013) Sleep and circadian rhythm dysregulation in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 43:209–216CrossRefPubMed Monti JM, BaHammam AS, Pandi-Perumal SR, Bromundt V, Spence DW, Cardinali DP, Brown GM (2013) Sleep and circadian rhythm dysregulation in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 43:209–216CrossRefPubMed
go back to reference Motivala SJ (2011) Sleep and inflammation: psychoneuroimmunology in the context of cardiovascular disease. Ann Behav Med 42:141–152CrossRefPubMed Motivala SJ (2011) Sleep and inflammation: psychoneuroimmunology in the context of cardiovascular disease. Ann Behav Med 42:141–152CrossRefPubMed
go back to reference Motivala SJ, Sarfatti A, Olmos L, Irwin MR (2005) Inflammatory markers and sleep disturbance in major depression. Psychosom Med 67:187–194CrossRefPubMed Motivala SJ, Sarfatti A, Olmos L, Irwin MR (2005) Inflammatory markers and sleep disturbance in major depression. Psychosom Med 67:187–194CrossRefPubMed
go back to reference Nishino S, Mignot E, Benson KL, Zarcone VP Jr (1998) Cerebrospinal fluid prostaglandins and corticotropin releasing factor in schizophrenics and controls: relationship to sleep architecture. Psychiatry Res 78:141–150CrossRefPubMed Nishino S, Mignot E, Benson KL, Zarcone VP Jr (1998) Cerebrospinal fluid prostaglandins and corticotropin releasing factor in schizophrenics and controls: relationship to sleep architecture. Psychiatry Res 78:141–150CrossRefPubMed
go back to reference Noto C, Maes M, Ota VK, Teixeira AL, Bressan RA, Gadelha A, Brietzke E (2015) High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance. World J Biol Psychiatry. doi:10.3109/15622975.2015.1062552 Noto C, Maes M, Ota VK, Teixeira AL, Bressan RA, Gadelha A, Brietzke E (2015) High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance. World J Biol Psychiatry. doi:10.​3109/​15622975.​2015.​1062552
go back to reference Opp M, Obal F, Krueger JM (1989) Corticotropin-releasing factor attenuates interleukin 1-induced sleep and fever in rabbits. Am J Physiol 257:528–535 Opp M, Obal F, Krueger JM (1989) Corticotropin-releasing factor attenuates interleukin 1-induced sleep and fever in rabbits. Am J Physiol 257:528–535
go back to reference Porkka-Heiskanen T, Zitting KM, Wigren HK (2013) Sleep, its regulation and possible mechanisms of sleep disturbances. Acta Physiol (Oxf) 208:311–328CrossRef Porkka-Heiskanen T, Zitting KM, Wigren HK (2013) Sleep, its regulation and possible mechanisms of sleep disturbances. Acta Physiol (Oxf) 208:311–328CrossRef
go back to reference Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E (2008) Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63:801–808CrossRefPubMed Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E (2008) Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63:801–808CrossRefPubMed
go back to reference Prather AA, Rabinovitz M, Pollock BG, Lotrich FE (2009) Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality. Brain Behav Immun 23:1109–1116CrossRefPubMedPubMedCentral Prather AA, Rabinovitz M, Pollock BG, Lotrich FE (2009) Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality. Brain Behav Immun 23:1109–1116CrossRefPubMedPubMedCentral
go back to reference Redwine L, Dang J, Hall M, Irwin M (2003) Disordered sleep, nocturnal cytokines, and immunity in alcoholics. Psychosom Med 65:75–85CrossRefPubMed Redwine L, Dang J, Hall M, Irwin M (2003) Disordered sleep, nocturnal cytokines, and immunity in alcoholics. Psychosom Med 65:75–85CrossRefPubMed
go back to reference Ritter PS, Kretschmer K, Pfennig A, Soltmann B (2013) Disturbed sleep in bipolar disorder is related to an elevation of IL-6 in peripheral monocytes. Med Hypotheses 81:1031–1033CrossRefPubMed Ritter PS, Kretschmer K, Pfennig A, Soltmann B (2013) Disturbed sleep in bipolar disorder is related to an elevation of IL-6 in peripheral monocytes. Med Hypotheses 81:1031–1033CrossRefPubMed
go back to reference Savitz J, Preskorn S, Teague TK, Drevets D, Yates W, Drevets W (2012) Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2 × 2 clinical trial. BMJ Open 22(2):e000643CrossRef Savitz J, Preskorn S, Teague TK, Drevets D, Yates W, Drevets W (2012) Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2 × 2 clinical trial. BMJ Open 22(2):e000643CrossRef
go back to reference Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe’er I, Dudbridge F, Holmans PA et al (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460:753–757PubMedPubMedCentral Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe’er I, Dudbridge F, Holmans PA et al (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460:753–757PubMedPubMedCentral
go back to reference Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, Chrousos GP (2004) Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 89:2119–2126CrossRefPubMed Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, Chrousos GP (2004) Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 89:2119–2126CrossRefPubMed
go back to reference Voderholzer U, Fiebich BL, Dersch R, Feige B, Piosczyk H, Kopasz M, Riemann D, Lieb K (2012) Effects of sleep deprivation on nocturnal cytokine concentrations in depressed patients and healthy control subjects. J Neuropsychiatry Clin Neurosci 24:354–366CrossRefPubMed Voderholzer U, Fiebich BL, Dersch R, Feige B, Piosczyk H, Kopasz M, Riemann D, Lieb K (2012) Effects of sleep deprivation on nocturnal cytokine concentrations in depressed patients and healthy control subjects. J Neuropsychiatry Clin Neurosci 24:354–366CrossRefPubMed
go back to reference von Kanel R, Dimsdale JE, Ancoli-Israel S, Mills PJ, Patterson TL, McKibbin CL, Archuleta C, Grant I (2006) Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin D-dimer in older caregivers of people with Alzheimer’s disease. J Am Geriatr Soc 54:431–437CrossRef von Kanel R, Dimsdale JE, Ancoli-Israel S, Mills PJ, Patterson TL, McKibbin CL, Archuleta C, Grant I (2006) Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin D-dimer in older caregivers of people with Alzheimer’s disease. J Am Geriatr Soc 54:431–437CrossRef
go back to reference Weschenfelder J, Sander C, Kluge M, Kirkby KC, Himmerich H (2012) The influence of cytokines on wakefulness regulation: clinical relevance, mechanisms and methodological problems. Psychiatr Danub 24:112–126PubMed Weschenfelder J, Sander C, Kluge M, Kirkby KC, Himmerich H (2012) The influence of cytokines on wakefulness regulation: clinical relevance, mechanisms and methodological problems. Psychiatr Danub 24:112–126PubMed
go back to reference Wichniak A, Jarema M (2012) Cytokines, sleep and wakefulness regulation, and general health: a commentary to the review “The influence of cytokines on wakefulness regulation”. Psychiatr Danub 24:127–129PubMed Wichniak A, Jarema M (2012) Cytokines, sleep and wakefulness regulation, and general health: a commentary to the review “The influence of cytokines on wakefulness regulation”. Psychiatr Danub 24:127–129PubMed
go back to reference Wisor JP, Schmidt MA, Clegern WC (2011) Evidence for neuroinflammatory and microglial changes in the cerebral response to sleep loss. Sleep 34(3):261–272PubMedPubMedCentral Wisor JP, Schmidt MA, Clegern WC (2011) Evidence for neuroinflammatory and microglial changes in the cerebral response to sleep loss. Sleep 34(3):261–272PubMedPubMedCentral
go back to reference Zeitzer JM (2013) Control of sleep and wakefulness in health and disease. Prog Mol Biol Transl Sci 119:137–154CrossRefPubMed Zeitzer JM (2013) Control of sleep and wakefulness in health and disease. Prog Mol Biol Transl Sci 119:137–154CrossRefPubMed
go back to reference Zhu B, Dong Y, Xu Z, Gompf HS, Ward SA, Xue Z, Miao C, Zhang Y, Chamberlin NL, Xie Z (2012) Sleep disturbance induces neuroinflammation and impairment of learning and memory. Neurobiol Dis 48:348–355CrossRefPubMedPubMedCentral Zhu B, Dong Y, Xu Z, Gompf HS, Ward SA, Xue Z, Miao C, Zhang Y, Chamberlin NL, Xie Z (2012) Sleep disturbance induces neuroinflammation and impairment of learning and memory. Neurobiol Dis 48:348–355CrossRefPubMedPubMedCentral
go back to reference Zielinski MR, Kim Y, Karpova SA, McCarley RW, Strecker RE, Gerashchenko D (2014) Chronic sleep restriction elevates brain interleukin-1 beta and tumor necrosis factor-alpha and attenuates brain-derived neurotrophic factor expression. Neurosci Lett 580c:27–31CrossRef Zielinski MR, Kim Y, Karpova SA, McCarley RW, Strecker RE, Gerashchenko D (2014) Chronic sleep restriction elevates brain interleukin-1 beta and tumor necrosis factor-alpha and attenuates brain-derived neurotrophic factor expression. Neurosci Lett 580c:27–31CrossRef
Metadata
Title
Sleep and inflammatory markers in different psychiatric disorders
Authors
Krzysztof Krysta
Marek Krzystanek
Agnieszka Bratek
Irena Krupka-Matuszczyk
Publication date
01-02-2017
Publisher
Springer Vienna
Published in
Journal of Neural Transmission / Issue Special Issue 1/2017
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-015-1492-3

Other articles of this Special Issue 1/2017

Journal of Neural Transmission 1/2017 Go to the issue

Psychiatry and Preclinical Psychiatric Studies - Original Article

Sustained attention in adult ADHD: time-on-task effects of various measures of attention

Psychiatry and Preclinical Psychiatric Studies - Review article

How does healthy aging impact on the circadian clock?

Psychiatry and Preclinical Psychiatric Studies - Original Article

Altered serum fatty acid composition in geriatric depression